Bibliography
1. Bell K.N., Oakley G.P. Jr. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res. A Clin. Mol. Teratol. 2009. 85. 102-107.
2. Botto L.D., Lisi A., Robert-Gnansia E. et al. International retrospective cohort study of neural tube defects in relation to folic acid re–commendations: are the recommendations working? Br. Med. J. 2005. 330. 571.
3. Brough L., Rees G.A., Crawford M.A. et al. Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status. J. Hum. Nutr. Diet. 2009. 22. 100-107.
4. Busby A., Abramsky L., Dolk H. et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod. Toxicol. 2005. 20. 393-402.
5. CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 1992. 41(RR-14). 1-7. Accessed on March 5, 2013.
6. CDC. Spina bifida and anencephaly before and after folic acid mandate — United States, 1995–1996 and 1999–2000. MMWR. 2004. 53. 362-365. Accessed on November 13, 2012.
7. CDC. Folate status in women of childbearing age, by race/ethnicity — United States, 1999–2000, 2001–2002, and 2003–2004. MMWR. 2007. 55. 1377-1380. Accessed on March 5, 2013.
8. Chitty L.S., Winter R.M. Perinatal mortality in different ethnic groups. Arch. Dis. Child. 1989. 64. 1036-041.
9. Clark N.A., Fisk N.M. Minimal comp–liance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br. J. Obstet. Gynaecol. 1994. 101. 709-710.
10. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992. 327. 1832-1835.
11. De Wals P., Tairou F., Van Allen M.I. et al. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 2007. 357. 135-142.
12. Dex S, Joshi H. 2004. Millennium cohort study first survey: a user’s guide to initial findings. Accessed on March 5, 2013.
13. Dowd J.B., Aiello A.E. Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int. J. Epidemiol. 2008. 37. 1059-1066. ]
14. Dunlap B., Shelke K., Salem S.A. et al. Folic acid and human reproduction-ten important issues for clinicians. J. Exp. Clin. Assist. Reprod. 2011. 8. 2.
15. EUROCAT. 2009. Special report: prevention of neural tube defects by periconceptional folic acid supplementation in Europe. Accessed on March 19, 2012.
16. Gatineau M., Mathrani S. Ethnicity and obesity in the UK. Perspect. Public Health. 2011. 131. 159-160.
17. De Marco P., Merello E., Calevo M.G. et al. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J. Hum. Genet. 2006. 2(51). 98-103.
18. Li S.Y., Rong M., Iacopetta B. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer. Oncol. Rep. 2006. 1(15). 221-225.
19. Wang L., Ke Q., Chen W. et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin. Cancer Res. 2007. 8(13). 2526-2532. odine Global Net work. Global Scorecard of Iodine Nutr ition 2017 in the general population and in pregnant women (PW). 2017; Available at: http://www.ign.org/cm_data/IGN_Global_Scorecard_AllPop_ and_PW_May2017.pdf. Accessed 06/08, 2017
20. Iodine Global Net work. Global Scorecard of Iodine Nutrition 2017 in the general population and in pregnant women (PW). 2017.
21. Iodine supplements factsheet for consumers and health professionals. NHMRC. 16.03.2018.
22. Давыдова Ю.В., Апресова К.Г., Чибисова И.В., Огородник А.А. и др. Перинатальный менеджмент при заболеваниях щитовидной железы: синопсис и алгоритмы. Репродуктивная эндокринология. 2012. № 5(7). С. 17-21.
23. Давыдова Ю.В. Фолиеводефицитные состояния и роль их коррекции в профилактике акушерских и перинатальных осложнений. Перинатология и педиатрия. 2018. № 1(73). С. 63-68. doi 10.15574/PP.2018.73.63.
24. Профилактика нарушений мета–болизма гомоцистеина и дефицита фолиевой кислоты: значение для снижения частоты перинатальных и соматических осложнений у женщин. Перинатология и педиатрия. 2018. № 2(74). С. 57-60. doi 10.15574/PP.2018.74.57
25. Давыдова Ю.В. Обеспечение защитных концентраций фолиевой кислоты для профилактики перинатальных осложнений. Перинатология и педиатрия. 2018. № 4(76). С. 17-20. doi 10.15574/PP.2018.76.17.
26. Давыдова Ю.В. Нарушения метаболизма гомоцистеина и дефицит фолиевой кислоты: значение профилактики в снижении частоты перинатальных и соматических осложнений у женщин. Здоровье Украины. 2018. № 2. С. 35-36.
27. Wright A.J., Dainty J.R., Finglas P.M. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br. J. Nutr. 2007 Oct. 98(4). 667-75. Epub 2007 Jul 9.